Journal For Clinical Studies

Current Edition

Current Features

Current features

Automation in Clinical Trials

Increasing Sophistication Requires Strategies for Adoption As clinical trials have become more complex with more moving parts, so too have the requirements for te...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Addressing Missing Data in Clinical Trials –The Data Science Approach

Digital Health Technologies (DHTs) have revolutionized clinical trial data collection, while also promising to make research more efficient and more patient-centric....

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

FDA’s New Draft Guidance for Psychedelic Drugs Opens Doors for Drug Developers in the US

In July 2023, Australia became the first country to permit psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin for use in psychedelic-...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

EU CTR Pushes Sponsors and CROs to Clean Up Their Act

The European Medicines Agency’s plan to harmonise all clinical trial information requires a significant change in how companies collect and store trial data and reco...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Focus on End-to-end Innovation and Efficiency Drives Life Sciences Service Provider Consolidation

The world has changed in Life Sciences and innovation and efficiency have become key to survival. Pharma manufacturers and marketing authorisation holders in the Lif...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Advancing NIPT Workflows:

Using Size Selection to Enrich Fetal Fraction, Enabling Extended Blood Storage in EDTA tubes Prenatal screening for Down’s Syndrome and other chromosomal imbalanc...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current Edition

Current features

Automation in Clinical Trials

Increasing Sophistication Requires Strategies for Adoption As clinical trials have become more complex with more moving parts, so too have the requirements for te...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Addressing Missing Data in Clinical Trials –The Data Science Approach

Digital Health Technologies (DHTs) have revolutionized clinical trial data collection, while also promising to make research more efficient and more patient-centric....

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

FDA’s New Draft Guidance for Psychedelic Drugs Opens Doors for Drug Developers in the US

In July 2023, Australia became the first country to permit psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin for use in psychedelic-...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

EU CTR Pushes Sponsors and CROs to Clean Up Their Act

The European Medicines Agency’s plan to harmonise all clinical trial information requires a significant change in how companies collect and store trial data and reco...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Focus on End-to-end Innovation and Efficiency Drives Life Sciences Service Provider Consolidation

The world has changed in Life Sciences and innovation and efficiency have become key to survival. Pharma manufacturers and marketing authorisation holders in the Lif...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Current features

Advancing NIPT Workflows:

Using Size Selection to Enrich Fetal Fraction, Enabling Extended Blood Storage in EDTA tubes Prenatal screening for Down’s Syndrome and other chromosomal imbalanc...

4 October 2023 Current features | Volume 15 Issue 3

Continue Reading →

Company Profiles

Uncategorised

Catalyst Clinical Research

Catalyst is a clinical research organization (CRO) that provides highly customizable solutions to the global biopharmaceutical industry through two established, bran...

22 February 2023 Uncategorised | Company Profile

Continue Reading →